Evolution of drug resistance in experimental populations of Candida albicans.

Cowen, L E; Sanglard, D; Calabrese, D; Sirjusingh, C; Anderson, J B; Kohn, L M

Cowen, L E; Sanglard, D; Calabrese, D; Sirjusingh, C; Anderson, J B; Kohn, L M.

Affiliation

Cowen LE; Department of Botany, University of Toronto, Mississauga, Ontario, Canada L5L 1C6. lcowen@credit.erin.utoronto.ca

J Bacteriol ; 182(6): 1515-22, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10692355

Subject(s)

Antifungal Agents/pharmacology; Candida albicans/drug effects; Candida albicans/genetics; Evolution, Molecular; Fluconazole/pharmacology; AIDS-Related Opportunistic Infections/microbiology; Candida albicans/growth & development; Candida albicans/isolation & purification; Candidiasis, Oral/microbiology; Colony Count, Microbial; Culture Media; DNA Fingerprinting; Drug Resistance, Microbial/genetics; Humans; Karyotyping; Loss of Heterozygosity; Microbial Sensitivity Tests; Sequence Analysis, DNA

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Candida albicans / Fluconazole / Evolution, Molecular / Antifungal Agents Limits: Humans Language: En Journal: J Bacteriol Year: 2000 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google